United Therapeutics Corporation / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €3.89B +12.9% €1.71B +20.6% 44.1% +0.028 pp €1.81B +25.0% 46.4% +0.045 pp
    (estimated) €3.44B +13.4% €1.42B +21.1% 41.3% +0.026 pp €1.44B +32.8% 41.9% +0.061 pp
    (estimated) €3.04B +4.9% €1.17B +1.8% 38.6% -0.012 pp €1.09B +6.8% 35.8% +0.0064 pp
    (estimated) €2.90B +5.7% €1.15B +4.9% 39.8% -0.0030 pp €1.02B +5.2% 35.2% -0.0019 pp
    (estimated) €2.74B +11.6% €1.10B +7.8% 40.1% -0.014 pp €968.71M -27.8% 35.4% -0.19 pp
    €2.45B +23.6% €1.02B +21.4% 41.5% -0.0078 pp €1.34B +30.2% 54.7% +0.028 pp
    €1.99B +20.2% €839.99M +35.4% 42.3% +0.048 pp €1.03B +28.4% 51.9% +0.033 pp
    €1.65B +14.9% €620.35M +52.9% 37.6% +0.093 pp €802.88M +30.9% 48.6% +0.060 pp
    €1.44B +13.6% €405.83M -7.6% 28.2% -0.065 pp €613.27M -11.8% 42.7% -0.12 pp
    €1.27B +2.4% €439.10M -592.6% 34.7% +0.42 pp €695.16M -763.1% 54.9% +0.63 pp
    €1.24B -11.0% -€89.13M -117.7% -7.2% -0.43 pp -€104.83M -112.8% -8.5% -0.68 pp
    €1.39B -5.7% €502.56M +41.0% 36.2% +0.12 pp €821.22M +71.8% 59.1% +0.27 pp
    €1.47B +7.9% €356.45M -41.4% 24.2% -0.20 pp €478.08M -18.4% 32.5% -0.10 pp
    €1.36B +9.1% €608.75M +9.5% 44.6% +0.0018 pp €585.81M +58.8% 43.0% +0.13 pp
    €1.25B +13.8% €555.82M +91.6% 44.5% +0.18 pp €368.98M +7.4% 29.5% -0.017 pp
    €1.10B +15.4% €290.07M +94.8% 26.4% +0.11 pp €343.52M -11.9% 31.3% -0.097 pp
    €952.73M +21.9% €148.89M -42.7% 15.6% -0.18 pp €389.95M +5.0% 40.9% -0.066 pp
    €781.37M +23.3% €259.67M +39.7% 33.2% +0.039 pp €371.49M +52.2% 47.5% +0.090 pp
    €633.90M +23.1% €185.83M +105.7% 29.3% +0.12 pp €244.09M +24.3% 38.5% +0.0039 pp
    €515.04M +63.3% €90.34M +444.2% 17.5% +0.12 pp €196.33M +19.2% 38.1% -0.14 pp
    €315.46M +31.4% €16.60M -145.5% 5.3% +0.20 pp €164.64M +156.5% 52.2% +0.25 pp
    €240.10M +33.4% -€36.50M -315.5% -15.2% -0.25 pp €64.18M -14.2% 26.7% -0.15 pp
    €179.92M +32.1% €16.94M -73.2% 9.4% -0.37 pp €74.84M +30.1% 41.6% -0.0064 pp
    €136.16M +37.7% €63.09M +13.8% 46.3% -0.098 pp €57.50M +35.3% 42.2% -0.0074 pp
    €98.87M +57.5% €55.46M +320.8% 56.1% +0.35 pp €42.49M +91.6% 43.0% +0.077 pp
    €62.77M +38.0% €13.18M -255.0% 21.0% +0.40 pp €22.17M -1,768.5% 35.3% +0.38 pp
    €45.50M +77.1% -€8.50M -57.8% -18.7% +0.60 pp -€1.33M -91.7% -2.9% +0.59 pp
    €25.69M +425.5% -€20.17M -36.6% -78.5% +5.7 pp -€15.93M -51.1% -62.0% +6.0 pp
    €4.89M +179.7% -€31.80M -50.7% -650.6% +30 pp -€32.59M +25.4% -666.7% +8.2 pp
    €1.75M +412.3% -€64.49M +125.7% -3,689.6% +47 pp -€25.99M +42.4% -1,487.1% +39 pp
    €341.18K +300.0% -€28.57M +161.7% -8,375.0% +44 pp -€18.25M +148.8% -5,350.0% +33 pp
    €85.30K -€10.92M -12,800.0% -€7.34M -8,600.0%

    Notifications